Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often stress the potential for substantial therapeutic gains, particularly in ailments where conventional therapies have proven ineffective. However, crucially important to evaluate the significant financial expenditure associated with